Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan/Amlodipine FDC vs Amlodipine in Hypertensive T2DM Patients
NCT00877929Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 2009
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of telmisartan in hypertension (HTN), sponsored by Boehringer Ingelheim. Started Feb 2009; status: completed.
02
Drugs
telmisartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00877929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00877929.